State Street’s X4 Pharmaceuticals XFOR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$29.5K Sell
15,534
-86,302
-85% -$164K ﹤0.01% 4164
2025
Q1
$722K Sell
101,836
-74
-0.1% -$525 ﹤0.01% 3509
2024
Q4
$2.24M Buy
101,910
+3,480
+4% +$76.6K ﹤0.01% 3284
2024
Q3
$1.98M Buy
98,430
+6,304
+7% +$127K ﹤0.01% 3334
2024
Q2
$1.6M Buy
92,126
+8,007
+10% +$139K ﹤0.01% 3387
2024
Q1
$3.51M Buy
84,119
+3,193
+4% +$133K ﹤0.01% 3073
2023
Q4
$2.04M Buy
80,926
+1,638
+2% +$41.2K ﹤0.01% 3306
2023
Q3
$2.59M Buy
79,288
+5,302
+7% +$173K ﹤0.01% 3219
2023
Q2
$4.31M Buy
73,986
+68,298
+1,201% +$3.97M ﹤0.01% 3068
2023
Q1
$148K Hold
5,688
﹤0.01% 4171
2022
Q4
$169K Buy
5,688
+3,864
+212% +$115K ﹤0.01% 4169
2022
Q3
$94K Hold
1,824
﹤0.01% 4482
2022
Q2
$53K Hold
1,824
﹤0.01% 4712
2022
Q1
$96K Buy
1,824
+208
+13% +$10.9K ﹤0.01% 4653
2021
Q4
$111K Hold
1,616
﹤0.01% 4557
2021
Q3
$256K Hold
1,616
﹤0.01% 4261
2021
Q2
$315K Sell
1,616
-7,612
-82% -$1.48M ﹤0.01% 4032
2021
Q1
$2.38M Sell
9,228
-4,436
-32% -$1.15M ﹤0.01% 3367
2020
Q4
$2.64M Sell
13,664
-439
-3% -$84.7K ﹤0.01% 3252
2020
Q3
$2.86M Buy
14,103
+93
+0.7% +$18.9K ﹤0.01% 3055
2020
Q2
$3.92M Buy
14,010
+4,845
+53% +$1.35M ﹤0.01% 2884
2020
Q1
$2.75M Buy
9,165
+3,343
+57% +$1M ﹤0.01% 2918
2019
Q4
$1.87M Buy
5,822
+1,088
+23% +$349K ﹤0.01% 3274
2019
Q3
$1.81M Buy
4,734
+2,036
+75% +$776K ﹤0.01% 3251
2019
Q2
$1.21M Buy
2,698
+2,108
+357% +$949K ﹤0.01% 3387
2019
Q1
$308K Sell
590
-5
-0.8% -$2.61K ﹤0.01% 3520
2018
Q4
$248K Sell
595
-113
-16% -$47.1K ﹤0.01% 3540
2018
Q3
$205K Buy
708
+343
+94% +$99.3K ﹤0.01% 3601
2018
Q2
$239K Buy
365
+52
+17% +$34K ﹤0.01% 3548
2018
Q1
$1.29M Buy
+313
New +$1.29M ﹤0.01% 3300